Clinical trial
Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Children With Sickle Cell Anemia ( DREPAGREFFE-2)
NCT05053932 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Creteil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Children With Sickle Cell Anemia ( DREPAGREFFE-2)
- Lead sponsor
- Centre Hospitalier Intercommunal Creteil
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 7, 2022
- Completion date
- January 31, 2025
- Enrollment
- 67 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral ischemia, sickle cell disease, stenosis